Rare diseases
Investigational molecules
Locations
Study of Camizestrant and CDK4/6 Inhibitor for Patients with Advanced Breast Cancer with ESR1 Mutation
PortugalStudy on JDQ443 and Docetaxel for Patients with Advanced KRAS G12C Mutant Non-Small Cell Lung Cancer
PortugalStudy of FNP-223 tablets to slow disease progression in patients with Progressive Supranuclear Palsy (PSP)
PortugalStudy on the Effects of Digoxin and Activated Charcoal in Treating Heart Failure in Patients Receiving Standard Care
PortugalStudy of BT8009 Alone or with Pembrolizumab for Patients with Advanced or Metastatic Bladder Cancer
PortugalStudy on the Effectiveness and Safety of Eplontersen for Patients with Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM)
PortugalStudy on BI 1015550 for Improving Lung Function in Patients with Progressive Fibrosing Interstitial Lung Diseases
PortugalStudy on the Effects of Isatuximab with Bortezomib, Lenalidomide, and Dexamethasone for Patients with Newly Diagnosed Multiple Myeloma Not Eligible for Transplant
PortugalStudy on the Safety and Effectiveness of Acasunlimab and Pembrolizumab for Patients with Recurrent Non-Small Cell Lung Cancer
PortugalStudy of Sotatercept for Newly Diagnosed Intermediate- and High-risk Pulmonary Arterial Hypertension Patients
PortugalStudy on Long-Term Safety of Etrasimod Arginine for Patients with Moderately to Severely Active Ulcerative Colitis
PortugalStudy on the Effects of Sparsentan and Irbesartan for Patients with Primary Focal Segmental Glomerulosclerosis (FSGS)
PortugalTell us about your condition – we search every trial in Europe and connect you with the right site.
